T. Rowe Price Investment Management Adds $94M in BrightSpring Health Services, Inc. ($BTSG)
Key Points
- T. Rowe Price Investment Management changed its BrightSpring Health Services, Inc. ($BTSG) stake by 24.6% last quarter, boosting to 7,629,151 shares worth $478.50 million.
- Wall Street's consensus rating on $BTSG is Strong Buy and an average price target of $62.56.
- $BTSG last traded around $62.72.
T. Rowe Price Investment Management increased its position in BrightSpring Health Services, Inc. ($BTSG) by 24.6% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,629,151 shares of BrightSpring Health Services, Inc. after buying 1,505,286 shares during the quarter. T. Rowe Price Investment Management's holdings in BrightSpring Health Services, Inc. were worth $478.50 million as of its most recent filing.
BrightSpring Health Services, Inc. ($BTSG) Stock
BrightSpring Health Services, Inc. Earnings
Analysts Set New Price Targets
About BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.